Industry News
Beacon Therapeutics Initiates VISTA Trial with AGTC-501 for X-Linked RP

Beacon Therapeutics announced the treatment of the first patient in its pivotal VISTA clinical trial...

read more
Beacon Therapeutics Initiates VISTA Trial with AGTC-501 for X-Linked RP
June 13, 2024
Oculis' Licaminlimab Demonstrates Promising Results in Phase 2B RELIEF Trial for DED

Oculis Holding announced positive topline results from its phase 2b RELIEF trial, shedding light on ...

read more
Oculis' Licaminlimab Demonstrates Promising Results in Phase 2B RELIEF Trial for DED
June 12, 2024
Skye Bioscience Shifts Focus After Phase 2 Glaucoma Trial Fails

Skye Bioscience's phase 2a clinical trial of its SBI-100 ophthalmic emulsion in patients with primar...

read more
Skye Bioscience Shifts Focus After Phase 2 Glaucoma Trial Fails
June 11, 2024
Nidek Receives CE Mark for NP-1/NP-1C Preloaded IOL Injection System

Nidek announced that it has received the CE Mark for its NP-1/NP-1C Preloaded IOL Injection System....

read more
Nidek Receives CE Mark for NP-1/NP-1C Preloaded IOL Injection System
June 11, 2024
Melt Pharmaceuticals Initiates Phase 3 Program for MELT-300 Opioid-Free Sedation

Melt Pharmaceuticals has completed the dosing of its first patient in its phase 3 program for MELT-3...

read more
Melt Pharmaceuticals Initiates Phase 3 Program for MELT-300 Opioid-Free Sedation
June 07, 2024
Rayner Announces Three Key Appointments to Management Board

Rayner has made three key additions to its management board to foster continued growth and developme...

read more
Rayner Announces Three Key Appointments to Management Board
June 06, 2024
Harrow Announces Promising 52-Week Data from Vevye ESSENCE-2 Clinical Study

Harrow, a leading pharmaceutical company, has revealed the encouraging results from its ESSENCE 2 op...

read more
Harrow Announces Promising 52-Week Data from Vevye ESSENCE-2 Clinical Study
June 06, 2024
Eversight Teams Up with LighTopTech to Improve Imaging Modalities for Eye Tissues

Eversight has partnered up with LighTopTech to elevate the standards of imaging modalities for eye t...

read more
Eversight Teams Up with LighTopTech to Improve Imaging Modalities for Eye Tissues
June 06, 2024
CorneaGen Launches CTAK: A Novel Solution for Keratoconus Patients

CorneaGen, a leading provider of ocular tissue, announced the commercial launch of Corneal Tissue Ad...

read more
CorneaGen Launches CTAK: A Novel Solution for Keratoconus Patients
June 05, 2024
BIOPHTA Raises €6.5M to Advance Eye Disease Therapies to Clinical Stage

BIOPHTA, a preclinical biotech company, has successfully closed a Seed round, raising €6.5 million t...

read more
BIOPHTA Raises €6.5M to Advance Eye Disease Therapies to Clinical Stage
June 05, 2024
More